These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3967559)

  • 1. Inhibition of pancreatic exocrine secretion and bile entry into the duodenum by isometheptene, a sympathomimetic agent.
    Gullo L; Priori P; Daniele C; Ventrucci M; Pezzilli R; Labo G
    Dig Dis Sci; 1985 Feb; 30(2):114-8. PubMed ID: 3967559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans.
    Lam WF; Masclee AA; Souverijn JH; Lamers CB
    Life Sci; 1999; 64(8):617-26. PubMed ID: 10069525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function.
    Malagelada JR; Go VL; DiMagno EP; Summerskill WH
    J Clin Invest; 1973 Sep; 52(9):2160-5. PubMed ID: 4727454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W; Lankisch PG; Fölsch UR
    Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of pirenzepine, a new muscarinic antagonist drug, on human pancreatic secretion.
    Nishimura S; Laugier R; Sarles H
    Scand J Gastroenterol; 1985 Oct; 20(8):990-4. PubMed ID: 3841228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic secretion in man after stimulation with cholecystokinin-pancreozymin, secretin and bile. Methods and normal ranges (author's transl)].
    Otte M; Stahlheber H; Zoelch M; Forell MM; Thurmayr GR; Thurmayr R
    Klin Wochenschr; 1973 Sep; 51(18):915-20. PubMed ID: 4762191
    [No Abstract]   [Full Text] [Related]  

  • 7. Na-taurodeoxycholate acts as a specific intestinal stimulus of exocrine pancreatic secretion in man.
    Lehnert P; Hempen I; Fiedler F; Hotz E; Danzl C; Mitra H; Riepl R
    Scand J Gastroenterol Suppl; 1987; 139():14-9. PubMed ID: 2448866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
    Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
    Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic secretion of patients with chronic renal insufficiency (author's transl)].
    Otte M; Stahlheber H; Forell MM; Dobbelstein H; Richert J; Thurmayr R; Thurmayr GR
    Klin Wochenschr; 1975 Jan; 53(2):67-72. PubMed ID: 1142706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic excretion of 5, 5-dimethyl-2, 4-oxazolidinedione in normal subjects.
    Noda A; Hayakawa T; Nakajima S; Suzuki T; Toda Y
    Am J Dig Dis; 1975 Nov; 20(11):1011-8. PubMed ID: 1199991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing sensitivities of gallbladder and pancreas to cholecystokinin-pancreozymin (CCK-PZ) in man.
    Malagelada JR; Go VL; Summerskill WH
    Gastroenterology; 1973 May; 64(5):950-4. PubMed ID: 4700421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of caerulein on the exocrine pancreas function in man; examinations of dose effects and comparisons with the effect of cholecystokinin/pankreozymin (author's transl)].
    Otte M; Forell MM
    Klin Wochenschr; 1979 Aug; 57(15):789-92. PubMed ID: 491501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of caerulein on total and ionized calcium secretion in the duodenal juice of man.
    Pfeiffer A; Lohse J; Kuntzen O
    Digestion; 1984; 30(4):242-50. PubMed ID: 6510575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of measurement of pancreatic function after stimulation with cholecystokinin-pancreozymin, secretin and bile (author's transl)].
    Otte M; Stahlheber H; Lehnert P; Forell MM
    Klin Wochenschr; 1973 Sep; 51(18):921-5. PubMed ID: 4762192
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoreactive secretin release following taurocholate perfusions of the cat duodenum.
    Hanssen LE; Hotz J; Hartmann W; Nehls W; Goebell H
    Scand J Gastroenterol; 1980; 15(1):89-95. PubMed ID: 7367827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of isometheptene on gallbladder contraction].
    Baldassarre G; Vasti MP; Carrieri V; Acquaviva M; Palasciano G
    Boll Soc Ital Biol Sper; 1983 Sep; 59(9):1278-84. PubMed ID: 6626361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of secretin-pancreozymin-stimulated pancreatic secretion, gallbladder contraction and choleresis after somatostatin administration].
    von Kleist D; Zschiedrich M; Stopik D; Hampel KE
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(5):219-24. PubMed ID: 6173190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminal bile regulates cholecystokinin release in conscious rats.
    Nakamura R; Miyasaka K; Kuyama Y; Kitani K
    Dig Dis Sci; 1990 Jan; 35(1):55-60. PubMed ID: 2295295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man.
    Riepl RL; Reichardt B; Rauscher J; Tzavella K; Teufel J; Lehnert P
    Eur J Med Res; 1997 Jan; 2(1):23-9. PubMed ID: 9049590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastase secretion in pancreatic disease.
    Mizuno R; Hayakawa T; Noda A
    Am J Gastroenterol; 1985 Feb; 80(2):113-7. PubMed ID: 3844284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.